missing translation for 'onlineSavingsMsg'
Learn More
Please login to your online account to display your discounted pricing

Promega ApoLive-Glo™ Multiplex Assay DFS Item

The ApoLive-Glo™ Multiplex Assay measures both the number of viable cells as a marker of cytotoxicity and caspase activation as a marker of apoptosis within a single assay well to determine the mechanism of cell death.

$2,542.08 - $2,542.08

Specifications

Detection Method Fluorescence, Luminescence
For Use With (Application) Profile Compounds for Cytotoxic Risk
View More Specs

Includes: GF-AFC Substrate, Assay Buffer, Caspase-Glo 3/7 Buffer, Caspase-Glo 3/7 Substrate

Products 1
Catalog Number Mfr. No. Kit Contents Quantity Price Quantity  
Catalog Number Mfr. No. Kit Contents Quantity Price Quantity  
PRG6411 DFS Item
View Documents Promotion Details
Promega
G6411
1 x 50 μL GF-AFC substrate, 2 x 10 mL Assay Buffer, 5 x 10 mL Caspase-Glo™ 3/7 Buffer, 5 x 1 bottle Caspase-Glo™ 3/7 substrate 5 x 10 mL
Each for $2,542.08
 
Description

Description

  • Measure Viability and Apoptosis in the Same Sample Well
  • Accurately determine mechanism of cell death in less time, with less sample
  • Easy to implement using a simple sequential 'add-mix-measure' protocol
  • Adaptable to meet various throughput needs
Specifications

Specifications

Fluorescence, Luminescence
Profile Compounds for Cytotoxic Risk
SDS
Product Certifications

U.S. Patents 7,416,854; 7,553,632 and other patents pending.
U.S. Patents 6,602,677 and 7,241,584, Australian Patents 754312 and 785294 and other patents and patents pending.
U.S. Patents 7,148,030 and 7,384,758, Australian Patent 2003216139 and other patents pending.
The method of recombinant expression of Coleoptera luciferase is covered by U.S. Patents 5,583,024, 5,674,713 and 5,700,673.